GeNose UGM Got Ministry Of Health Permit, Can You Sell It For Personal?

GeNose made by UGM (Photo via UGM official website)

YOGYAKARTA - GeNose, made by UGM experts, which only takes 3 minutes through a breath to detect COVID-19, has officially received a distribution permit from the Ministry of Health (KEMENKES RI AKD 20401022883). GeNose UGM will later be placed in public transportation spaces such as airports and stations.

The head of the GeNose development team, Prof. Kuwat Triyana, said that the GeNose distribution permit from the Ministry of Health was issued on Thursday, December 24. Now GeNose UGM can be marketed.

"Alhamdulillah, thanks to the prayers and extraordinary support from many parties, GeNose C19 officially obtained a distribution permit (KEMENKES RI AKD 20401022883) to start getting recognition by regulators, namely the Ministry of Health, in helping to deal with Covid-19 through rapid screening," wrote Kuwat in a statement. he wrote.

The UGM GeNose development team - financed by BIN and the Ministry of Research and Technology / National Agency for Research and Technology - immediately handed over 100 units of the mass production of the first batch. It was calculated by UGM, one GeNose tool can perform 120 tests or a total of 12 thousand people a day.

"The figure of 120 tests per device is based on the estimation that each test takes 3 minutes including taking a breath so that one hour can test 20 people and if it is effective the tool works for 6 hours," said Kuwat.

GeNose C19 is expected to be placed at airports, train stations and other crowded places including hospitals. Including the BNPB which can be mobile approaching suspect Covid-19. However, Kuwat said, this stage does not allow the procurement of GeNose C19 for personal use.

Kuwat also emphasized that after obtaining a distribution permit, the GeNose C19 will soon be mass produced. The team hopes that if there are 1,000 units in the future it will be able to test as many as 120 thousand people a day, and if there are 10 thousand units (according to the target at the end of February 2021) then Indonesia will show the highest number of Covid-19 tests per day in the world, namely 1.2. million people per day.

"Of course, it is not only figures like that we all hope, but that much capacity is expected to find people infected with COVID-19 without symptoms (OTG) and immediately take isolation or treatment measures so that the chain of Covid-19 spread can soon be cut, "Said Kuwat.

Five consortium industries are committed to support, namely PT. Yogya Presisi Tehnikatama Industri (mechanical part), PT. Hikari Solusindo Sukses (electronics and sensors), PT. Stechoq Robotika Indonesia (pneumatic), PT. Nanosense Instrument Indonesia (artificial intelligence, electronics and after sales), and PT. Swayasa Prakarsa (assembly, licensing, standards, QC / QA, business).

The test fee with the GeNose C19 is quite cheap, only around Rp. 15-25 thousand. The test result is also very fast, which is about 2 minutes and does not require reagents or other chemicals. In addition, taking a test sample in the form of a breath exhalation also feels more comfortable than a swab or swab.